Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Wei, Xiaolong ^a   Zhang, Donghong ^b   Dou, Xiaowei ^a   Niu, Na ^c   Huang, Wenhe ^a   Bai, Jingwen ^a   Zhang, Guojun ^a  

^a CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Cytochrome P450; Migration; Proliferation; Soluble epoxide hydrolase

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2J2; EPOXIDE HYDROLASE; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MESSENGER RNA; SMALL INTERFERING RNA; 14,15-EPOXY-5,8,11-EICOSATRIENOIC ACID; ARACHIDONATE EPOXYGENASE; CYTOCHROME P450; DIHOMO GAMMA LINOLENIC ACID;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CELL MIGRATION; CELL PROLIFERATION; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME DEGRADATION; ENZYME SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MDA MB 231 CELL LINE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR VOLUME; UPREGULATION; AGED; ANALOGS AND DERIVATIVES; BREAST TUMOR; CELL MOTION; DISEASE COURSE; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SPACE; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

8,11,14-EICOSATRIENOIC ACID; ADULT; AGED; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYTOCHROME P-450 CYP2C8; CYTOCHROME P-450 CYP2C9; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE PROGRESSION; EPOXIDE HYDROLASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SPACE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; TUMOR BURDEN;

EID: 84988591530     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-841     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
2. Lizarraga IM, Sugg SL, Weigel RJ, Scott-Conner CE: Review of risk factors for the development of contralateral breast cancer. Am J Surg 2013, 206(5):704-708.
3. Jiang JG, Chen CL, Card JW, Yang S, Chen JX, Fu XN, Ning YG, Xiao X, Zeldin DC, Wang DW: Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res 2005, 65(11):4707-4715.
4. Zhang D, Zhang Q, Zhou L, Huo L, Zhang Y, Shen Z, Zhu Y: Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16,-18 and-58 in esophageal and cervical cancer: a case-control study. BMC Cancer 2010, 10:650.
5. Panigrahy D, Greene ER, Pozzi A, Wang DW, Zeldin DC: EET signaling in cancer. Cancer Metastasis Rev 2011, 30(3-4):525-540.
6. Panigrahy D, Edin ML, Lee CR, Huang S, Bielenberg DR, Butterfield CE, Barnés CM, Mammoto A, Mammoto T, Luria A, Benny O, Chaponis DM, Dudley AC, Greene ER, Vergilio JA, Pietramaggiori G, Scherer-Pietramaggiori SS, Short SM, Seth M, Lih FB, Tomer KB, Yang J, Schwendener RA, Hammock BD, Falck JR, Manthati VL, Ingber DE, Kaipainen A, D'Amore PA, Kieran MW, et al: Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Invest 2012, 122(1):178-191.
7. Yang S, Lin L, Chen JX, Lee CR, Seubert JM, Wang Y, Wang H, Chao ZR, Tao DD, Gong JP, Lu ZY, Wang DW, Zeldin DC: Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways. Am J Physiol Heart Circ Physiol 2007, 293(1):H142-H151.
8. Guo M, Roman RJ, Falck JR, Edwards PA, Scicli AG: Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of CYP4A. J Pharmacol Exp Ther 2005, 315(2):526-533.
9. Imig JD, Hammock BD: Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov 2009, 8(10):794-805.
10. Enayetallah AE, French RA, Grant DF: Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms. J Mol Histol 2006, 37(3-4):133-141.
11. Chen C, Wei X, Rao X, Wu J, Yang S, Chen F, Ma D, Zhou J, Dackor RT, Zeldin DC, Wang DW: Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth. J Pharmacol Exp Ther 2011, 336(2):344-355.
12. Leclerc J, Tournel G, Courcot-Ngoubo NE, Pottier N, Lafitte JJ, Jaillard S, Mensier E, Lhermitte M, Broly F, Lo-Guidice JM: Profiling gene expression of whole cytochrome P450 superfamily in human bronchial and peripheral lung tissues: Differential expression in non-small cell lung cancers. Biochimie 2010, 92(3):292-306.
13. Murray GI, Patimalla S, Stewart KN, Miller ID, Heys SD: Profiling the expression of cytochrome P450 in breast cancer. Histopathology 2010, 57(2):202-211.
14. Roques M, Bagrel D, Magdalou J, Siest G: Expression of arylhydrocarbon hydroxylase, epoxide hydrolases, glutathione S-transferase and UDPglucuronosyltransferases in H5-6 hepatoma cells. Gen Pharmacol 1991, 22(4):677-684.
15. Yang MD, Wu CC, Chiou SH, Chiu CF, Lin TY, Chiang IP, Chow KC: Reduction of dihydrodiol dehydrogenase expression in resected hepatocellular carcinoma. Oncol Rep 2003, 10(2):271-276.
16. Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H, Masaoka A: The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002, 94(3):624-632.
17. Zhang D, Xie X, Chen Y, Hammock BD, Kong W, Zhu Y: Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Circ Res 2012, 110(6):808-817.
18. Liu Y, Chen Z, Niu N, Chang Q, Deng R, Korteweg C, Gu J: IgG gene expression and its possible significance in prostate cancers. Prostate 2012, 72(6):690-701.
19. Zhang D, Ai D, Tanaka H, Hammock BD, Zhu Y: DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism. Biochim Biophys Acta 2010, 1799(9):659-667.
20. Mitra R, Guo Z, Milani M, Mesaros C, Rodriguez M, Nguyen J, Luo X, Clarke D, Lamba J, Schuetz E, Donner DB, Puli N, Falck JR, Capdevila J, Gupta K, Blair IA, Potter DA: CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (+/-)-14, 15-epoxyeicosatrienoic acid (EET). J Biol Chem 2011, 286(20):17543-17559.
21. Jiang JG, Ning YG, Chen C, Ma D, Liu ZJ, Yang S, Zhou J, Xiao X, Zhang XA, Edin ML, Card JW, Wang J, Zeldin DC, Wang DW: Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res 2007, 67(14):6665-6674.
22. Wang D, Dubois RN: Epoxyeicosatrienoic acids: a double-edged sword in cardiovascular diseases and cancer. J Clin Invest 2012, 122(1):19-22.
23. Zhang D, Chen Y, Xie X, Liu J, Wang Q, Kong W, Zhu Y: Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells. J Mol Cell Cardiol 2012, 53(4):487-496.
24. Skrypnyk N, Chen X, Hu W, Su Y, Mont S, Yang S, Gangadhariah M, Wei S, Falck JR, Jat JL, Zent R, Capdevila JH, Pozzi A: PPARalpha Activation Can Help Prevent and Treat Non-Small Cell Lung Cancer. Cancer Res 2014, 74(2):621-631.
25. Zagorac D, Jakovcevic D, Gebremedhin D, Harder DR: Antiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiforme. J Cereb Blood Flow Metab 2008, 28(8):1431-1439.
26. Homma S1, Koido S, Sagawa Y, Suzuki H, Komita H, Nagasaki E, Takahara A, Horiguchi-Yamada J, Tajiri H, Zeldin DC, Obata T: Antigenic stimulation with cytochrome P450 2 J expressed in mouse hepatocellular carcinoma cells regulates host anti-tumour immunity. Clin Exp Immunol 2009, 156(2):344-352.
27. Chen F, Chen C, Yang S, Gong W, Wang Y, Cianflone K, Tang J, Wang DW: Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2. PLoS One 2012, 7(6):e39197.
28. Zhang SY, Surapureddi S, Coulter S, Ferguson SS, Goldstein JA: Human CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liver. Mol Pharmacol 2012, 82(3):529-540.
29. Spector AA: Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res 2009, 50(Suppl):S52-S56.
30. Liu L, Chen C, Gong W, Li Y, Edin ML, Zeldin DC, Wang DW: Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide. J Pharmacol Exp Ther 2011, 339(2):451-463.